The Texas A&；M University System;The Regents of the University of Colorado, a Body Corporate
发明人:
Richard Tobin,Martha Karen Newell-Rogers
申请号：
US16646391
公开号：
US20200268831A1
申请日:
2018.09.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to methods for treating cancers by targeting the elimination of selective activated immune cell populations in combination with checkpoint inhibitors. The cells may be targeted, for instance, using CLIP inhibitors and or MHC class II inducers.
